Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Slade

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
BMJ Open|November 12, 2021
CATALYST trial protocol: a multicentre, open-label, phase II, multiarm trial for an early and accelerated evaluation of the potential treatments for COVID-19 in hospitalised adultsTonny Veenith, Benjamin A Fisher, Daniel Slade, et al.
Cancer Research Communications|June 1, 2026
Ceralasertib Monotherapy in Patients with ATM-Altered Advanced Solid Tumors or Metastatic Castration-Resistant Prostate Cancer: Data from the Phase 2a PLANETTE StudyRahul R Aggarwal, Antoine Italiano, Susan M Domchek, et al.
The Lancet. Respiratory Medicine|December 19, 2021
Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trialBenjamin A Fisher, Tonny Veenith, Daniel Slade, et al.
Journal of Medicinal Chemistry|November 3, 2025
Use of Direct-to-Biology Strategies for the Discovery of 2'-Deoxynucleoside 5'-Monophosphate N-Glycosidase (DNPH1) PROTACsNiall A Anderson, Bernard Barlaam, Argyrides Argyrou, et al.
Cell Reports|March 28, 2019
Blockade of MCU-Mediated Ca<sup>2+</sup> Uptake Perturbs Lipid Metabolism via PP4-Dependent AMPK DephosphorylationDhanendra Tomar, Fabián Jaña, Zhiwei Dong, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
BMJ Open|November 12, 2021
CATALYST trial protocol: a multicentre, open-label, phase II, multiarm trial for an early and accelerated evaluation of the potential treatments for COVID-19 in hospitalised adultsTonny Veenith, Benjamin A Fisher, Daniel Slade, et al.
Cancer Research Communications|June 1, 2026
Ceralasertib Monotherapy in Patients with ATM-Altered Advanced Solid Tumors or Metastatic Castration-Resistant Prostate Cancer: Data from the Phase 2a PLANETTE StudyRahul R Aggarwal, Antoine Italiano, Susan M Domchek, et al.
The Lancet. Respiratory Medicine|December 19, 2021
Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trialBenjamin A Fisher, Tonny Veenith, Daniel Slade, et al.
Journal of Medicinal Chemistry|November 3, 2025
Use of Direct-to-Biology Strategies for the Discovery of 2'-Deoxynucleoside 5'-Monophosphate N-Glycosidase (DNPH1) PROTACsNiall A Anderson, Bernard Barlaam, Argyrides Argyrou, et al.
Cell Reports|March 28, 2019
Blockade of MCU-Mediated Ca<sup>2+</sup> Uptake Perturbs Lipid Metabolism via PP4-Dependent AMPK DephosphorylationDhanendra Tomar, Fabián Jaña, Zhiwei Dong, et al.
Pageof 2